Trades on 3 secondary markets

Accent Therapeutics

Accent Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of small-molecule precision cancer therapies that target critical intracellular dependencies spanning multiple types of cancer. Its pipeline is led by ATX-295, a novel KIF18A inhibitor in clinical development, w

minimal 14.3 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Pharmaceuticals Oncology Precision Medicine

Accent Therapeutics is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.